1. Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 5: Linkage of Fragments C1-6 and C7-24 and Finale
- Author
-
Frederick Ray Kinder, Robert Daeffler, Ernst Kuesters, Weichun Chen, Emil Schmid, Run-Ming Wang, Daniel Niederer, Kapa Prasad, Remo Gamboni, Karl Schaer, Ian Paterson, Isabelle Lyothier, Adnan Osmani, Stuart J. Mickel, Kurt Königsberger, Gordon J. Florence, Loeser Eric M, Oljan Repic, and Timothy Michael Ramsey
- Subjects
chemistry.chemical_compound ,Natural product ,chemistry ,Aldol reaction ,Longest linear sequence ,Stereochemistry ,Organic Chemistry ,Stereoselectivity ,Sequence (biology) ,Discodermolide ,Physical and Theoretical Chemistry ,Adduct ,Stereocenter - Abstract
The finale of the large-scale preparation of 60 g of the highly complex marine natural product, (+)-discodermolide (1), using a hybridized Novartis−Smith−Paterson synthetic route is presented. This contribution, which is the concluding part of a five-part series, highlights a reagent-controlled stereoselective boron enolate aldol reaction between 2 and 3 forming the C7 hydroxyl-bearing stereocenter, selective reduction of 4a to generate the 1,3-anti-diol 5, and a global deprotection and concomitant lactonization leading to (+)-discodermolide (1). A novel procedure for converting the minor epimeric aldol adduct 4b into discodermolide using a five-step sequence is also described. This large-scale synthesis of discodermolide involved 39 steps (26 steps in the longest linear sequence) and several chromatographic purifications and delivered sufficient material for early-stage human clinical trials.
- Published
- 2003
- Full Text
- View/download PDF